Chihuahua Puppy Tries Strawberries and Dramatically Loses Her Tiny Mind
There's nothing cuter than a little puppy trying a new food for the first time, especially if the little pup has a reaction like this tiny Chihuahua encountering her first taste of strawberries.
She hops, she bounces, she lunges, she goes in for the attack, and backs her booty up. We can't tell if she loves the fruit or wants to fight it, but either way, she's too cute for it to matter.
One person asked, "Is that a dog rabbit? It looks mixed." Another person said, "Oh, she is just about the cutest thing ever."
She really is! Those strawberries are almost bigger than she is!You may be wondering if it's OK for your own dog or puppy to eat strawberries, and the answer is yes. Strawberries are a safe and healthy treat for dogs when served properly and eaten in moderation.
PetMD explains, "Strawberries boast several health benefits for dogs. Not only are they high in immune system-boosting vitamins, including vitamins C, B-1, B-6, and K, but they're also loaded with fiber and contain omega-3, which helps support coat health."
It's important to keep portion sizes small, especially with little puppies, because too many berries can cause an upset stomach, and no one wants that!
Another precaution the article does mention is that whole strawberries can be a choking hazard, especially for small pups. Always slice strawberries into smaller pieces before serving. Remove the stems and leaves, too, so they don't become a choking hazard or cause intestinal blockages.
So, as cute as it may be seeing a tiny puppy next to a big bowl of strawberries, safety first, so cut up the fruit so your fur baby can safely enjoy it.
🐶SIGN UP to get 'pawsitivity' delivered right to your inbox with inspiring & entertaining stories about our furry & feathered friends🐾🐾
Chihuahua Puppy Tries Strawberries and Dramatically Loses Her Tiny Mind first appeared on Parade Pets on Jul 6, 2025
This story was originally reported by Parade Pets on Jul 6, 2025, where it first appeared.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
23 minutes ago
- Yahoo
2 Stocks to Buy on the Dip and Hold for 10 Years
Novo Nordisk's shares look attractive after a terrible performance over the past 12 months. DexCom has significant room to grow in its core market, despite disappointing results last year. 10 stocks we like better than Novo Nordisk › One of Warren Buffett's famous pieces of investing advice is to be greedy when others are fearful. One way to apply this wisdom is to look for companies that have lagged the market recently but still appear to be excellent long-term investment opportunities. Two great examples today in the healthcare sector are Novo Nordisk (NYSE: NVO) and DexCom (NASDAQ: DXCM). Although these two corporations have encountered significant headwinds since last year, they could deliver market-beating returns to investors who initiate positions today and stick with them for at least a decade. Novo Nordisk is coming off clinical setbacks and unimpressive financial results, at least by its lofty standards. The stock has significantly underperformed the market over the trailing-12-month period. But after this beating, the company's shares look attractive. Here are several reasons why. First, although Novo Nordisk's eternal rival, Eli Lilly, appears to be taking the lead in the fast-growing weight management market, the former still has excellent prospects in this rapidly expanding therapeutic area. Novo Nordisk's Wegovy continues to grow its sales at a good clip, and the company is awaiting approval from the U.S. Food and Drug Administration for an oral formulation of this popular medicine. Further, Novo Nordisk has promising internally developed pipeline candidates, such as amycretin, which recently entered phase 3 studies. The Denmark-based drugmaker has also enhanced its pipeline in this area, thanks to licensing deals and acquisitions. Second, Novo Nordisk has been working on diversifying its lineup and currently has promising pipeline candidates outside of its core treatment areas of diabetes and obesity. Novo Nordisk is developing medicines for conditions including hemophilia, Parkinson's disease, sickle cell disease, Alzheimer's disease, and others. Third, after being southbound for the past 12 months, Novo Nordisk's shares look reasonably valued. The company's forward price-to-earnings ratio is 16.8, compared to the 16.3 average for the healthcare industry. Novo Nordisk's financial results over the past year have been terrific by industry standards, but not quite what the market expected. That may have justified the sell-off, but at current levels, the stock looks attractive. Finally, Novo Nordisk is a solid dividend-paying company. It has increased its annual dividend per share by almost 284% over the past decade, while offering a forward yield of 2.3%. That's not exceptional, but it's above the S&P 500 index's average of 1.3%. Novo Nordisk is well-positioned to bounce back and deliver strong returns in the next decade as it rides weight management (and other) tailwinds. DexCom is a leading diabetes-focused medical device company. It develops continuous glucose monitoring (CGM) systems that help diabetics with constant blood sugar level measurements. DexCom has been successful thanks to the increased adoption of this innovative technology. Unlike blood glucose meters that are manually operated, use pesky and painful fingersticks, and can only tell a person's sugar level at one point in time, CGM devices are constantly monitoring things and automatically make measurements as often as every five minutes. Rrevenue and earnings have grown rapidly over the past decade, but the company hit a speed bump last year when its top-line growth slowed considerably, partly due to higher-than-expected rebates in the U.S., resulting in lower revenue per patient. That said, these are short-term issues that do little to impact the company's long-term prospects. And on that front, there are still plenty of reasons to be excited about DexCom's future. Consider that the company has ample room to grow, even in the U.S., a country that enjoys higher CGM penetration than most others. However, as DexCom has consistently pointed out, the population of patients who use CGM continues to lag behind those who are eligible for third-party coverage -- in other words, many people could obtain the technology paid for by insurers but have not yet opted in. Further, there is a vast worldwide opportunity, since only a tiny percentage of the diabetics in the world use CGM technology. Though many are in countries where DexCom does not do business, the company has generally increased its addressable market by entering new geographies. In the next 10 years, expect the company to do the same while benefiting from greater insurance coverage for CGM -- third-party payers, including governments, have been more willing to foot the bill because of the technology's benefits. All that should lead to consistent revenue and earnings growth for the medical device specialist. The stock has crushed the market in the past decade using this formula. In my view, it is well-positioned to do the same through 2035. Before you buy stock in Novo Nordisk, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Novo Nordisk wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $699,558!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $976,677!* Now, it's worth noting Stock Advisor's total average return is 1,060% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 30, 2025 Prosper Junior Bakiny has positions in Eli Lilly and Novo Nordisk. The Motley Fool recommends DexCom and Novo Nordisk and recommends the following options: long January 2027 $65 calls on DexCom and short January 2027 $75 calls on DexCom. The Motley Fool has a disclosure policy. 2 Stocks to Buy on the Dip and Hold for 10 Years was originally published by The Motley Fool
Yahoo
an hour ago
- Yahoo
Scientists Reveal What Happens to Your Body When You Drink Coffee Every Day
A new study linked daily coffee consumption to a potentially longer life. We asked experts to explain how the morning delicacy can have such an impact. There are a few catches. The ritual of brewing and sipping fresh coffee each morning is one many of us look forward to, and a new study's findings may give you the push to pour another cup. Researchers connected coffee consumption to mortality among a large population of participants and found that coffee may actually help you live longer, with a few caveats. Meet the Experts: David Perlmutter, M.D., a neurologist and fellow of the American College of Nutrition and Michelle Routhenstein, M.S., R.D., a cardiology dietitian at Entirely Nourished. Keep reading to learn more about how your daily cup of joe may offer you more than a jolt of energy and happiness. Researchers tracked the self-reported coffee drinking habits of over 46,000 U.S. adults for nearly a decade. Participants disclosed how they drank their java. Regular or decaf? With sugar and milk or without? If with, how much? They then compared that information to National Death Index data to deduce how coffee consumption could have impacted mortality from all causes, including cancer and heart disease. After examining the data, researchers found that drinking one to three cups of coffee per day was linked to a reduced risk of death from all causes, 'especially when the coffee is black or has minimal added sugar and saturated fat,' explains David Perlmutter, M.D., a neurologist and fellow of the American College of Nutrition. Specifically, they found that drinking black coffee or coffee with less than 2.5 grams (or a little more than a half-teaspoon) of sugar and less than a gram of saturated fat from milk or cream per 8-ounce cup was associated with a 14% lower risk of dying from any cause compared to not drinking coffee at all, Dr. Perlmutter adds. The catch here is, the study also found that most Americans add around 3.2 grams of sugar and a half-gram of saturated fat to each mug, which means the majority of coffee drinkers are less likely to get its life-extending benefits. 'This is the problem with so many coffee specialty drinks that seem to be so popular,' Dr. Perlmutter says. There is plenty of existing research that purports coffee's health boost. Without added sugar or fat, it's a naturally good source of antioxidants like polyphenols and chlorogenic acid, explains Dr. Purlmutter. 'These components and others help fight inflammation and oxidative stress,' he adds, both of which are contributors to chronic disease. That's how coffee may help reduce risk of type 2 diabetes, cardiovascular disease, and congnitive decline, 'all of which influence lifespan,' he concludes. Coffee's caffeine content can even exhibit perks by improving alertness, metabolism, and brain health, Dr. Pelrmutter says. However, there is such a thing as overdoing it and reaping negative side-effects such as anxiety, increased blood pressure, heart palpitations, digestive issues, and insomnia, says Michelle Routhenstein, M.S., R.D., a cardiology dietitian at Entirely Nourished. She adds that a 'very high coffee intake may also slightly reduce calcium absorption, potentially affecting bone health.' The study supports drinking one to three cups of black or minimally altered coffee per day. Dr. Perlmutter recommends keeping sugars below 2.5 grams and saturated fats below 1 gram per cup by using low-fat milk or plant-based creamer alternatives. Routhenstein adds that if you are pregnant or breastfeeding, or have otherwise been prescribed a specific caffeine intake, follow your doctor's recommendations. Lastly, to avoid over-caffeination, Dr. Perlmutter suggests enforcing a 'coffee curfew' that marks the time of day after which you turn off the pot. 'I generally recommend 2 p.m. to minimize coffee's impact on sleep,' he concludes. You Might Also Like Can Apple Cider Vinegar Lead to Weight Loss? Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50
CBS News
an hour ago
- CBS News
Glimmer of Hope provides just that to cancer patients
After waiting fifty years to find her forever partner, Tess Herzo got engaged to her husband in 2022. "The wedding celebration, all of it, is really important to be perfect," said Herzo. With five months until they tied the knot, doctors diagnosed her with breast cancer. "Then there's this punch in the gut that you get," she said. Herzo went through chemotherapy at Saint Clair's Cancer Center, with UPMC Hillman Cancer Center. "It was really, really hard," she said. "You don't feel great at all." All through her treatment, she kept a wedding goal in mind. "One of the most important things was to make sure I had hair on my head," Herzo said. That's where this new scalp cooling therapy comes into play. "Unfortunately, hair loss is something that's associated with the number of chemotherapies that we use, and so cooling caps have helped to try to minimize hair loss for patients going through chemotherapy," said St. Clair Hospital Cancer Center's Dr. Bob Vanderweele. Patients wear a cap on their head to cool the temperature of their scalp during hours of chemotherapy. It takes hours, but the Amma Scalp Cooling system is portable, and it made more of Herzo's hair stay in place for her dream wedding. Preventing hair loss is not vanity; it's emotional stability in the face of uncertainty. "Definitely made a difference that way. I can't remember being sad at all at that time. It was like we were just going to push through," said Herzo. Now with the non-profit Glimmer of Hope and St. Clair, it's at the hospital, in the South Hills. "That's amazing, the time that I was going through treatment," Herzo said. "I definitely wanted to see more women take advantage of it. I'm incredibly thankful to them. That they helped make this happen." It's also free for patients whose insurance won't cover it. "We're thrilled with this cold cap project," said Glimmer of Hope found Diana Napper. "We really try to support the patient completely through the journey, and obviously our goal is to cure," Napper said. The cool cap helps hide cancer treatment and provides a sense of normalcy. "I know a lot of women with kids say that they need to stay strong and look strong for their children," said Herzo. It's more than just hair care; during cancer treatment, it's a "Glimmer of Hope" for breast cancer patients during the darkest moments of their lives. Through fundraising and the donations from individuals, businesses, sports celebrities, and organizations, Glimmer of Hope's donated over $7,000,000 for breast cancer projects in our region. The non-profit's helped at least a thousand patients, funded cancer-curing research, and more. For more information on Glimmer of Hope, click here.
